EUCTR2018-000415-25-DE进行中（未招募）1 期
PANCREATIC RESECTION WITH PERIOPERATIVE OFF-LABEL STUDY OF PROPRANOLOL AND ETODOLAC – A PHASE II RANDOMIZED TRIA
niversity Hospital Heidelberg0 个研究点目标入组 80 人开始时间: 2018年6月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •· Patients planned for elective pancreatoduodenectomy
- •· Patients eligible for perioperative therapy with propranolol / etodolac
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 53
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 27
排除标准
- •· Prior / concurrent therapy with beta-blockers, Cox-2 inhibitors or
- •· Known allergies to beta-blockers, Cox-2 inhibitors or Etodolac
- •· Patients with a known long-term medication that may cause severe
- •interactions with propranolol / etodolac
研究者
相似试验
进行中（未招募）
2 期
Pancreatic resection with perioperative off-Label study of Propranolol and Etodolac - A Phase II randomized TrialC25.0Head of pancreasDRKS00014054niversitätsklinikum Heidelberg26
招募中
Unknown
Pancreatic REseCtion with level-III dissection versus versus standard pancreatic resection in patients with primary resected pancreatic head cancer – a single-center randomized controlled trialC25.0Head of pancreasDRKS00032727niklinik RWTH Aachen, Klinik für Allgemein-, Viszeral- & Transplantationschirurgie196
进行中（未招募）
不适用
Pancreatic cancer operation and development of diabetesCTRI/2013/12/004233AIIMS84
招募中
1 期
aparoscopic (laparoscopy-assisted) pancreaticoduodenectomyJPRN-UMIN000011316Oita University Faculty of Medicine20
已完成
不适用
Palliative pylorus-preserving pancreatic head resection and postoperative chemotherapy versus primary chemotherapy alone for patients with advanced carcinoma of the pancreatic headPancreatic head carcinomaCancerISRCTN20060588Humboldt University Berlin (Germany)20